MEK inhibition prevents TGF-β1-induced myofibroblast transdifferentiation in human tenon fibroblasts

Autor: Xianchai Lin, Yunlan Ling, Rongjiao Liu, Jiamin Wen, Bo Qu, Wuyou Gao, Minbin Yu
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Cancer Research
p38 mitogen-activated protein kinases
Down-Regulation
Biochemistry
Transforming Growth Factor beta1
03 medical and health sciences
Downregulation and upregulation
Cell Movement
Nitriles
Genetics
Butadienes
Humans
subconjunctival fibrosis
human tenon fibroblasts
RNA
Messenger

Phosphorylation
Protein kinase A
Myofibroblasts
Molecular Biology
transforming growth factor-β1
Cells
Cultured

Cell Proliferation
glaucoma filtration surgery
Chemistry
Kinase
Transdifferentiation
Cell Differentiation
Articles
Fibroblasts
Fibrosis
Actins
Cell biology
mitogen-activated protein kinase kinase inhibitor
030104 developmental biology
Oncology
Mitogen-Activated Protein Kinase Kinase Inhibitor
Cell Transdifferentiation
Molecular Medicine
Collagen
Snail Family Transcription Factors
Signal transduction
Mitogen-Activated Protein Kinases
Myofibroblast
Signal Transduction
Zdroj: Molecular Medicine Reports
ISSN: 1791-3004
1791-2997
Popis: Subconjunctival fibrosis represents the primary cause of postoperative failure of trabeculectomy, and at present there is a lack of effective intervention strategies. The present study aimed to investigate the effect of the mitogen‑activated protein kinase kinase (MEK) inhibitor U0126 on human tenon fibroblast (HTF) myofibrosis transdifferentiation, and to illuminate the underlying molecular mechanisms involved. It was demonstrated that U0126 significantly inhibited the proliferation, migration and collagen contraction of HTFs stimulated with TGF‑β1. In addition, U0126 largely attenuated the TGF‑β1‑induced conversion of HTFs into myofibroblasts, as indicated by a downregulation of the mRNA and protein expression of α‑smooth muscle actin and zinc finger protein SNAI1, and by ameliorating the 3D‑collagen contraction response. Mechanistically, U0126 suppressed the TGF‑β1‑stimulated phosphorylation of mothers against decapentaplegic homolog 2/3, P38 mitogen‑activated protein kinase and extracellular signal‑regulated kinase 1/2, indicating that U0126 may inhibit HTF activation through the canonical and non‑canonical signaling pathways of TGF‑β1. Therefore, U0126 exhibits a potent anti‑fibrotic effect among HTFs, and the inhibition of MEK signaling may serve as an alternative intervention strategy for the treatment of trabeculectomy‑associated fibrosis.
Databáze: OpenAIRE